Investing.com - Zimmer Biomet reported on Friday fourth quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Zimmer Biomet announced earnings per share of $2.11 on revenue of $2.09B. Analysts polled by Investing.com anticipated EPS of $2.07 on revenue of $2.09B.
Zimmer Biomet shares are up 4% from the beginning of the year and are trading at $160.73 , down-from-52-week-high.They are outperforming the S&P 500 which is up 3.08% from the start of the year.
Zimmer Biomet follows other major Healthcare sector earnings this month
Zimmer Biomet's report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Roche Holding ADR had missed expectations on Monday with fourth quarter EPS of $1.21 on revenue of $15.88B, compared to forecast for EPS of $1.28 on revenue of $17.17B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar